Brief: Celon Pharma Q2 Net Loss At 30.6 Million Zlotys
17/09/2026 05:47
BRIEF-Celon Pharma Q2 Net Loss At 30.6 Million Zlotys Sept 17 (Reuters) - Celon Pharma SA CLNP.WA:
REPORTS Q2 NET LOSS AT 30.6 MILLION ZLOTYS
Q2 REVENUE AT 60.1 MILLION ZLOTYS
Q2 OPERATING LOSS AT 9.5 MILLION ZLOTYS
Source text: nEMbFRkgLa
Further company coverage: CLNP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Celon Pharma SA
See all newsBrief: Celon Pharma Projects Recommended For About 29.9 Mln Zlotys Funding By Poland's Medical Research Agency
Brief: Celon Pharma Files Marketing Authorization Applications In EU For Semaglutide Drug Injection Solution
Brief: Celon Pharma Q2 Net Loss At 30.6 Million Zlotys
Brief: Celon Pharma Gets Positive Opinion Confirming Reduzek Compliance With Safety Requirements
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump